Julie Refardt - Endocrine Tumours Group

Julie Refardt, MD, PhD, is a dedicated clinical researcher specializing in endocrinology at the Erasmus Medical Center in Rotterdam, the Netherlands. With a strong foundation in both medicine and research, she is committed to advancing the understanding and treatment of complex neuroendocrine disorders.

Dr. Refardt began her academic journey in Basel, Switzerland, where she earned her MD from the University of Basel in 2009. She then pursued her specialization in internal medicine, completing it in 2015, followed by a specialization in endocrinology in 2017. Her clinical expertise provided the perfect platform for her transition into research, which began in 2013 with investigator-initiated clinical trials focusing on water-sodium disturbances. Her work in the field of AVP deficiency (central diabetes insipidus) and hyponatremia has led to multiple high-impact publications and her appointment as a member of international guideline committees.

In 2019, Dr. Refardt joined the Erasmus Medical Center in Rotterdam to expand her research into neuroendocrine disorders, which led to her PhD completion in 2023 at Erasmus University Rotterdam. After a brief return to Switzerland, Dr. Refardt came back to the Netherlands in 2023, where she now works as a staff member and research group leader. Her research is focused on enhancing diagnostic accuracy and treatment options for patients with neuroendocrine disorders such as AVP deficiency, acromegaly, Cushing’s disease and other pituitary disorders.

Links
ORCID: https://orcid.org/0000-0002-3040-4685

Research Gate: www.researchgate.net/profile/Julie-Refardt

Google scholar: https://scholar.google.com/citations?user=T55pSAsAAAAJ&hl=en